OptimizeRx
OPRX
OptimizeRx (OPRX) news
Recent news
OptimizerX names Andy D'Silva as CFO
OptimizeRx Corp. (Nasdaq: OPRX) has appointed Andrew D’Silva to the position of senior vice president of corporate finance, a role that includes strategic growth and capital markets . D’Silva brings over a decade of equity research and capital markets experience to the company, having previously…
AInvest Wire · Aug 12, 2026OptimizerX 2Q adj EPS 16c, est. 7.7c
AInvest Wire · Aug 12, 2026OptimizerX 2Q adj. EBITDA $4.94M, est. $2.34M
AInvest Wire · Aug 12, 2026OptimizerX still sees FY adj. EBITDA $21M to $25M
AInvest Wire · May 12, 2026OptimizerX sees FY revenue $95M to $100M
AInvest Wire · May 12, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.